TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -12.45%329.08M | 132.45%761.78M | 403.20%375.85M | -49.69%327.72M | -79.31%74.69M | 84.04%651.44M | 249.18%360.96M | 18.17%353.96M | 94.86%103.37M | 117.60%299.53M |
Operating income | -12.45%329.08M | 132.45%761.78M | 403.20%375.85M | -49.69%327.72M | -79.31%74.69M | 84.04%651.44M | 249.18%360.96M | 18.17%353.96M | 94.86%103.37M | 117.60%299.53M |
Cost of sales | 11.86%-307.81M | -133.63%-711.58M | -417.77%-349.24M | 48.75%-304.58M | 79.68%-67.45M | -80.61%-594.36M | -246.07%-331.86M | -16.83%-329.08M | -97.23%-95.89M | -115.92%-281.67M |
Operating expenses | 11.86%-307.81M | -133.63%-711.58M | -417.77%-349.24M | 48.75%-304.58M | 79.68%-67.45M | -80.61%-594.36M | -246.07%-331.86M | -16.83%-329.08M | -97.23%-95.89M | -115.92%-281.67M |
Gross profit | -20.12%21.26M | 116.91%50.2M | 267.55%26.62M | -59.46%23.14M | -75.11%7.24M | 129.46%57.08M | 289.00%29.1M | 39.29%24.88M | 68.85%7.48M | 148.19%17.86M |
Selling expenses | -137.93%-69K | -105.26%-39K | 89.22%-29K | 98.11%-19K | 64.09%-269K | -127.95%-1M | -438.85%-749K | 69.66%-440K | 81.32%-139K | -210.49%-1.45M |
Administrative expenses | 29.08%-4.09M | -33.28%-12.28M | -14.03%-5.77M | 45.50%-9.21M | 36.72%-5.06M | 11.91%-16.9M | 24.55%-8M | 24.60%-19.18M | 3.22%-10.6M | -16.67%-25.44M |
Profit from asset sales | ---- | ---- | ---- | ---24K | ---- | ---- | ---- | ---- | ---- | ---931K |
Revaluation surplus | 52.17%-11K | 50.36%-68K | 74.73%-23K | -175.27%-137K | -118.16%-91K | 367.65%182K | 586.41%501K | 57.23%-68K | -0.98%-103K | 66.81%-159K |
-Changes in the fair value of financial assets | 52.17%-11K | 50.36%-68K | 74.73%-23K | -175.27%-137K | -118.16%-91K | 367.65%182K | 586.41%501K | 57.23%-68K | -0.98%-103K | 66.81%-159K |
Impairment and provision | ---- | -480.09%-12.07M | --72K | 125.00%3.18M | ---- | -466.16%-12.7M | ---- | -4.23%-2.24M | ---- | ---2.15M |
-Other impairment is provision | ---- | -480.09%-12.07M | --72K | 125.00%3.18M | ---- | -466.16%-12.7M | ---- | -4.23%-2.24M | ---- | ---2.15M |
Special items of operating profit | -78.99%29K | 2,143.25%8.14M | -28.87%138K | -45.98%363K | -11.82%194K | -90.95%672K | -53.09%220K | 830.33%7.42M | 294.61%469K | -12.40%798K |
Operating profit | -18.50%17.12M | 96.01%33.89M | 942.43%21.01M | -36.75%17.29M | -90.44%2.02M | 163.70%27.34M | 828.09%21.07M | 190.35%10.37M | 61.98%-2.89M | 21.65%-11.47M |
Financing cost | -859.32%-4.22M | -879.66%-8.52M | 22.12%-440K | 86.48%-870K | 80.93%-565K | -22.64%-6.44M | 41.71%-2.96M | 38.82%-5.25M | -42.50%-5.08M | -24.72%-8.58M |
Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --59K | ---- | ---- |
Earning before tax | -37.28%12.9M | 54.49%25.37M | 1,318.28%20.57M | -21.44%16.42M | -91.99%1.45M | 303.67%20.9M | 327.00%18.11M | 125.82%5.18M | 28.64%-7.98M | 6.83%-20.05M |
Tax | 14.77%-3.39M | -369.90%-5.82M | -384.76%-3.98M | 75.66%-1.24M | 39.93%-820K | -1,873.26%-5.09M | -934.09%-1.37M | -119.05%-258K | 70.20%-132K | 378.60%1.35M |
After-tax profit from continuing operations | -42.68%9.51M | 28.75%19.55M | 2,533.33%16.59M | -3.98%15.18M | -96.24%630K | 221.36%15.81M | 306.47%16.74M | 126.31%4.92M | 30.22%-8.11M | 15.04%-18.7M |
Earning after tax | -42.68%9.51M | 28.75%19.55M | 2,533.33%16.59M | -3.98%15.18M | -96.24%630K | 221.36%15.81M | 306.47%16.74M | 126.31%4.92M | 30.22%-8.11M | 15.04%-18.7M |
Minority profit | 150.00%22K | -590.52%-801K | -193.62%-44K | -163.39%-116K | -97.72%47K | -55.26%183K | --2.06M | --409K | ---- | ---- |
Profit attributable to shareholders | -42.96%9.49M | 33.01%20.35M | 2,753.17%16.63M | -2.12%15.3M | -96.03%583K | 246.44%15.63M | 281.11%14.69M | 124.13%4.51M | 30.22%-8.11M | 15.04%-18.7M |
Basic earnings per share | -42.60%0.0097 | 32.69%0.0207 | 2,716.67%0.0169 | -1.89%0.0156 | -96.00%0.0006 | 245.65%0.0159 | 280.72%0.015 | 124.21%0.0046 | -170.34%-0.0083 | 15.18%-0.019 |
Diluted earnings per share | -42.60%0.0097 | 32.69%0.0207 | 2,716.67%0.0169 | -1.89%0.0156 | -96.00%0.0006 | 245.65%0.0159 | 280.72%0.015 | 124.21%0.0046 | -170.34%-0.0083 | 15.18%-0.019 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.